Role of Cerebrospinal Fluid Biomarkers in Clinical Trials for Alzheimer's Disease Modifying Therapies

Until now, a disease-modifying therapy (DMT) that has an ability to slow or arrest Alzheimer's disease (AD) progression has not been developed, and all clinical trials involving AD patients enrolled by clinical assessment alone also have not been successful. Given the growing consensus that the...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Korean J Physiol Pharmacol
Hoofdauteurs: Kang, Ju-Hee, Ryoo, Na-Young, Shin, Dong Wun, Trojanowski, John Q, Shaw, Leslie M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: The Korean Physiological Society and The Korean Society of Pharmacology 2014
Onderwerpen:
Review Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4296032/
https://ncbi.nlm.nih.gov/pubmed/25598657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4196/kjpp.2014.18.6.447
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items